Toggle navigation
Home
Search
Services
Blog
Contact
About
Monoclonal Antibody Assay for Apoliprproteins A-1 and B
Cowley, Daniel B.
Hybridoma Sciences, Inc., Fountain Valley, CA, United States
Search 3 grants from Daniel Cowley
Search grants from Hybridoma Sciences, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Genetic mechanisms that regulate left/right asymmetric neuron size
Womens Cancer Treatment Choices by Cohort and Ethnicity
Sphingomyelin and Biomembranes and Bilayers
Pathology of Retinal Dysfunction
Screening for Child Abuse
Recently added grants:
The role of neuroactive steroids in stress, drug craving and drug use in cocaine use disorders
Core B: Gene Modulation with RNAi and CRISPER
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
Sleep regulates drug relapse and addiction
Core C: Imaging: from Super-Resolution to Whole Animal
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44HL033043-02
Application #
3508401
Study Section
(SSS)
Project Start
1984-09-30
Project End
1988-06-09
Budget Start
1986-06-10
Budget End
1987-06-09
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Hybridoma Sciences, Inc.
Department
Type
DUNS #
City
Fountain Valley
State
CA
Country
United States
Zip Code
92708
Related projects
NIH 1987
R44 HL
Monoclonal Antibody Assay for Apoliprproteins A-1 and B
Foley, Thomas J. / Hybridoma Sciences, Inc.
NIH 1986
R44 HL
Monoclonal Antibody Assay for Apoliprproteins A-1 and B
Cowley, Daniel B. / Hybridoma Sciences, Inc.
Publications
Rothwell, T C; Kamanna, V S; Jin, F Y et al.
(1995)
Characterization of a monoclonal antibody (HB-22) and development of an ELISA for human apolipoprotein A-I.
Clin Chem 41:1150-8
Comments
Be the first to comment on Daniel Cowley's grant